Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
Visceral leishmaniasis (VL) is a vector-borne disease affecting humans and domestic animals that constitutes a serious public health problem in many countries. Although many antigens have been examined so far as protein- or DNA-based vaccines, none of them conferred complete long-term protection. Th...
Guardado en:
Autores principales: | Noushin Saljoughian, Tahereh Taheri, Farnaz Zahedifard, Yasaman Taslimi, Fatemeh Doustdari, Azam Bolhassani, Delaram Doroud, Hiva Azizi, Kazem Heidari, Mohammad Vasei, Nabiollah Namvar Asl, Barbara Papadopoulou, Sima Rafati |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/499954bbfcd346d18bbb91fe41e99e56 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Studies on Tongue of Reptilian Species Psammophis sibilans, Tarentola annularis and Crocodylus niloticus
por: El-Sayyad,Hassan I.H, et al.
Publicado: (2011) -
Leishmania tarentolae and Leishmania infantum in humans, dogs and cats in the Pelagie archipelago, southern Italy.
por: Roberta Iatta, et al.
Publicado: (2021) -
In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine
por: Ali Namvar, et al.
Publicado: (2019) -
TriQuinoline
por: Shinya Adachi, et al.
Publicado: (2019) -
Author Correction: TriQuinoline
por: Shinya Adachi, et al.
Publicado: (2020)